Description
Product Name:Huperzine
A
Application: Memory
Support
Source: Huperzia
serrata
Specification:
1%**8% Huperzine A By HPLC
Molecular Formula:
C*5H*8N2O
Molecular Mass:
**2.**6
CAS
NO: **********6
3.
Function
Huperzine A has potent pharmacological effects
and, particularly since long-term safety has not been determined,
it should only be used with medical supervision. It may have some
effectiveness in Alzheimer disease and age-related memory
impairment. It has been used to treat fever and some inflammatory
disorders, but there is no credible scientific evidence to support
these uses.
4. Safety
Concerns
Adverse effects reported with huperzine A
include gastrointestinal effects, such as nausea and diarrhea,
sweating, blurred vision, fasciculations and dizziness. Possible
adverse effects include vomiting, cramping, bronchospasm,
bradycardia, arrhythmias, seizures, urinary incontinence, increased
urination and hypersalivation.
Huperzine A should be avoided by children,
pregnant women and nursing
mothers.
Because of possible adverse effects in those
with seizure disorders, cardiac arrhythmias and asthma, those with
these disorders should avoid huperzine A. Those with irritable
bowel disease, inflammatory bowel disease and malabsorption
syndromes should avoid huperzine
A.
Continuous use of high doses of huperzine A
*-such as **0 mcg or more*- may be toxic. Due to its strong
anticholinesterase activity, huperzine a could cause a cholinergic
reaction. Huperzine side effects could include sweating, nausea,
vomiting, dizziness, and cramps.
5. Dosage
Information
Typical dosage recommendations for purified and
standardized HupA extracts are *0mcg, taken twice per day, although
doses of *****0mcg per day have been used in clinical studies to
treat Alzheimer’s disease, dementia, age-associated memory
impairment and senile memory
disorders.
